1. Startpage

Browsing by Author Michel, Martin C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
PreviewIssue dateOnline publication dateTitleAuthor(s)
analysis_of_16_studies_in_nin-20230119110200136.pdf.jpg202220-Jan-2023Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargementYesilyurt, Zeynep E.; Matthes, Jan; Hintermann, Edith; Castañeda, Tamara R.; Elvert, Ralf; Beltran-Ornelas, Jesus H.; Silvia-Velasco, Diana L.; Xia, Ning; Kannt, Aimo; Christen, Urs; Centurión, David; Li, Huige; Pautz, Andrea; Arioglu-Inan, Ebru; Michel, Martin C.
are_3adrenoceptor_gene_polymo-20230109123409827.pdf.jpg20239-Jan-2023Are β3-adrenoceptor gene polymorphisms relevant for urology?Michel, Martin C.
associations_between_the_pati-20230119102549593.pdf.jpg202219-Jan-2023Associations between the Patient Perception of Bladder Condition score and overactive bladder syndrome symptoms at baseline and upon treatmentSchönburg, Sandra; Murgas, Sandra; Fornara, Paolo; Michel, Martin C.
michel_martin_c.-choice_of_y-ax-20210416120339910.pdf.jpg20206-May-2021Choice of y-axis can mislead readersErdogan, Betül R.; Vollert, Jan; Michel, Martin C.
amiri_marjan-do_overactive_-20210824095701663.pdf.jpg202024-Aug-2021Do overactive bladder symptoms and their treatment-associated changes exhibit a normal distribution? Implications for analysis and reportingAmiri, Marjan; Murgas, Sandra; Stang, Andreas; Michel, Martin C.
does_coupling_to_adp_ribosyla-20221114162041326.pdf.jpg20223-Jan-2023Does coupling to ADP ribosylation factor 6 explain differences between muscarinic and other receptors in interaction with β-adrenoceptor-mediated smooth muscle relaxation?Erdogan, Betül R.; Michel, Martin C.
established_and_emerging_trea-20221117161215831.pdf.jpg20225-Jan-2023Established and emerging treatments for diabetes-associated lower urinary tract dysfunctionErdogan, Betül R.; Liu, Guiming; Arioglu-Inan, Ebru; Michel, Martin C.
michel_martin_c.-a_systematic_r-20201211103515253.pdf.jpg202014-Dec-2020A systematic review of inverse agonism at adrenoceptor subtypesMichel, Martin C.; Michel-Reher, Martina B.; Hein, Peter
a_teaching_tool_about_the_fic-20220812154906894.pdf.jpg202116-Aug-2022A teaching tool about the fickle p value and other statistical principles based on real-life dataAlawbathani, Salem; Batool, Mehreen; Fleckhaus, Jan; Hamad, Sarkawt; Hassenrück, Floyd; Hou, Yanhong; Li, Xia; Salmanton-García, Jon; Ullah, Sami; Wieters, Frederique; Michel, Martin C.
michel_martin_c.-where_will_the-20210826095649144.pdf.jpg202026-Aug-2021Where will the next generation of medical treatments for overactive bladder syndrome come from?Michel, Martin C.
a_year_in_pharmacology__new_d-20220822150015702.pdf.jpg202123-Aug-2022A year in pharmacology : new drugs approved by the US Food and Drug Administration in 2020Kayki-Mutlu, Gizem; Michel, Martin C.
a_year_in_pharmacology__new_d-20221117155652490.pdf.jpg20225-Jan-2023A year in pharmacology : new drugs approved by the US Food and Drug Administration in 2021Kayki-Mutlu, Gizem; Aksoyalp, Zinnet Sevval; Wojnowski, Leszek; Michel, Martin C.
Showing results 1 to 12 of 12